Esperion Therapeutics Inc's (NASDAQ: ESPR) cholesterol drug marketing strategy has soured badly, as it has been struggling to sell its heart disease pill for more than a year.
AstraZeneca’s Enhertu Posts Substantial Clinical Benefit Over Roche’s Kadcyla In Breast Cancer Trials
September 20, 4:11 PM
AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo's (OTC: DSNKY) Enhertu have shown some striking data in late-stage breast cancer trials and early solid tumor tests.
August 9, 4:06 PM
AstraZeneca plc (NASDAQ:AZN) and Daiichi Sankyo Co Ltd (OTC:DSKYF) have announced high-level results from the head-to-head DESTINY-Breast03 Phase 3 trial of Enhertu. The…
July 8, 1:26 PM
Daiichi Sankyo Co Ltd (OTC:DSKYF) and AstraZeneca plc (NASDAQ: AZN) have dosed the first patient in DESTINY-Gastric04, Phase 3 trial of Enhertu (trastuzumab deruxtecan)…
May 26, 6:56 AM
Japan’s Nipro Corporation has signed an agreement to supply AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine in Japan, reports Reuters. Nipro said that the…